N-glycan profile of anti-α-Gal antibodies. PNGase F-released N

Complete spatial characterisation of N-glycosylation upon striatal neuroinflammation in the rodent brain, Journal of Neuroinflammation

PDF) Purification and Characterization of Antibodies Directed against the α-Gal Epitope

Identification of global inhibitors of cellular glycosylation

PDF) Purification and Characterization of Antibodies Directed against the α-Gal Epitope

NP-HPLC profile of PNGase F released glycans from a recombinant

Sialic acid-containing glycolipids mediate binding and viral entry of SARS-CoV-2

Aberrant sialylation in a patient with a HNF1α variant and liver adenomatosis - ScienceDirect

Simplifying glycan monitoring of complex antigens such as the SARS-CoV-2 spike to accelerate vaccine development

N-glycan profile of anti-α-Gal antibodies. PNGase F-released N-glycans

Frontiers Mass Spectrometry Imaging for Glycome in the Brain

Assessing the Heterogeneity of the Fc-Glycan of a Therapeutic Antibody Using an engineered FcγReceptor IIIa-Immobilized Column

Glycan fluorescent profiles from human IgG released by EndoS 2 and

Glycan fluorescent profiles from human AGP released by PNGase F and

Frontiers N- and O-Glycosylation Pathways in the Microalgae Polyphyletic Group

A platform for qualitative and quantitative characterization of α-Gal and NeuGc at the oligosaccharide level - ScienceDirect